Matthew Hobson
Principal at Catalio Capital Management
Matthew Hobson
Principal at Catalio Capital Management
New York, New York
Overview
Work Experience
Principal
2023 - Current
Sr. Analyst
2020 - 2023
Sr. Analyst at Catalio Capital Management, a venture capital fund focused on breakthrough biomedical technologies
Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies.
Postdoctoral Researcher
2020 - 2021
PHD Candidate
2013 - 2020
PhD candidate in James Berger's lab. I utilize protein engineering and structural methods to investigate type II topoisomerases.
Undergraduate Researcher
2010 - 2013
Currently synthesizing and characterizing Nucleic Acid orthologs to understand factors effecting duplex thermodynamics and conformation. Worked on characterizing the binding site of the liker domain of the protein VirA of Agrobacterium Tumefaciens via affinity labeling and peptide mapping. VirA is part of the VirA/VirG system which initiates and mediates DNA transformation of plants. This is used a method of genetic modification.
Contractor
2010 - 2012
Conducting research in the National Institute of Biomedical Imaging and Bioengineering.
National Institutes of Health is a biomedical research facility that focuses on biomedical and health-related research.
Raised $5,000,000.00 from National Institute of Allergy and Infectious Diseases.
Intern
2009 - 2009
Participated in a DOD sponsored summer internship program. Worked on a malaria vaccine development project characterizing the optimal route of administration via ELISA.
Walter Reed Army Institute of Research (WRAIR) is the largest biomedical research facility administered by the U.S. Department of Defense